Patent expiration risk for total worldwide global Rx drug revenue 2024-2030

Published by
Matej Mikulic,
Nov 9, 2024

This statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2024 to 2030. In 2028, the industry is expected to have 100 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.

Forecast of total prescription drug revenue at risk worldwide from patent expiration from 2024 to 2030 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2024

Region

Worldwide

Survey time period

as of May 2024

Supplementary notes

‘Total Sales at Risk’ represents the worldwide product sales in the year before patent expiry but allocated to the year of expiry.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

6

Segments

6

Companies

8

R&D, patents, new products

7

Outlook

6

Review: COVID-19 response

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizerNovartis
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.